Artelo Biosciences to Showcase First-in-Human FABP5 Inhibitor ART26.12 as a Novel Approach to Pain Treatment at IASP 2026 World Congress on Pain Oct 26, 2026 07:55AM

Presentation will introduce ART26.12, the first selective FABP5 inhibitor to enter human clinical studies, to the world’s largest gathering of pain professionals

Growing body of data supports ART26.12’s potential as a novel, non-opioid treatment for pain as the Company advances toward a multiple ascending dose (MAD) study

SOLANA BEACH, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage... (continue reading...)


THC Drinks: BudPop Launches First Hemp-Derived THC Soda Line in Three Flavors at 5mg and 10mg Oct 26, 2026 07:47AM

Commerce, California, Oct. 26, 2026 (GLOBE NEWSWIRE) -- BudPop, the hemp-derived cannabinoid brand known for its gummies, vapes and flowers, today announced its first line of hemp-derived THC beverages [https://budpop.com/thc-drinks/]. The collection includes three flavors, Cran Razz, Blood Orange Pomegranate, and Cherry Lime Chill, each offered in 5 mg and 10 mg THC strengths (no CBD). Cran Razz is the lightest option in the lineup. The new THC drinks are sold... (continue reading...)


HI-VIEW IP SURVEY IDENTIFIES MULTIPLE POTENTIAL PORPHYRY TARGETS AT THE BLACK PEARL, TOODOGGONE REGION, BRITISH COLUMBIA Oct 26, 2026 07:45AM

VANCOUVER, BRITISH COLUMBIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- HI-VIEW RESOURCES INC. (“Hi-View” or the “Company”) (CSE: GXLD; OTCQB: GXLDF; FSE: B630) announces preliminary results from its 2026 exploration program at the Black Pearl target, part of its 100%-owned property in the Toodoggone District of north-central British Columbia (the “Property”).Preliminary results from the induced polarization (“IP”) survey, supported by geological mapping and field... (continue reading...)


NevGold Appoints Sean Waller to Board of Directors; Key Addition of Project Development and Mineral Process Engineering Expertise Oct 26, 2026 07:45AM

Vancouver, British Columbia, Oct. 26, 2026 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce the appointment of Mr. Sean I. Waller., M.Sc. Eng., FCIM, to its Board of Directors, effective immediately. Mr. Waller adds key project development experience to the NevGold Board of Directors at a time when the Company is entering the Engineering Phase.

NevGold CEO, Brandon Bonifacio, comments:... (continue reading...)


Partner1 Renews WBENC Women's Business Enterprise and Women-Owned Small Business Certifications Oct 26, 2026 07:42AM

PLEASANTVILLE, N.Y., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Partner1, the advisory firm and software platform behind the partnership strategies of fast-growing B2B software companies, today announced it has renewed its Women’s Business Enterprise (WBE) and Women-Owned Small Business (WOSB) certifications from the Women’s Business Enterprise National Council (WBENC), through the Women’s Business Enterprise Council (WBEC) Metro NY, a regional certifying partner of WBENC.... (continue reading...)


More Globe Newswire

View Older Stories

Oct 26, 2026 07:42AM Partner1 Renews WBENC Women's Business Enterprise and Women-Owned Small Business Certifications
Oct 26, 2026 07:37AM 22nd Century Expands the Pinnacle Pure Portfolio To 6 SKU’s With Addition of 100’s and Menthol Varieties
Oct 26, 2026 07:35AM VenHub and Follett Higher Education Form Strategic Partnership to Expand 24/7 Autonomous Retail Across College and University Campuses
Oct 26, 2026 07:30AM Lysander Funds Announces Listing of ETF Series of Lysander-Triasima Canadian Equity Fund
Oct 26, 2026 07:30AM All NIOB Bardy Holes Hit Meaningful TREO Grades in at Least One Interval
Oct 26, 2026 07:30AM FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
Oct 26, 2026 07:30AM Hypercharge to Present at Planet MicroCap Toronto 2026 and Announces Marketing Engagement
Oct 26, 2026 07:30AM Camping World Holdings, Inc. to Announce Third Quarter 2026 Earnings on November 2, 2026, with a Call Premarket on November 3, 2026
Oct 26, 2026 07:30AM BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives
Oct 26, 2026 07:30AM Maxus Mining Engages Understood Mineral Resources to Advance Resource-Focused Work at Quarry Project
Oct 26, 2026 07:30AM Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Oct 26, 2026 07:30AM Ocean Power Technologies and Stratum Holdings Sign Letter of Intent for Proposed Strategic Collaboration to Demonstrate Offshore Renewable-Powered Data Center Assets
Oct 26, 2026 07:30AM Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC
Oct 26, 2026 07:30AM Immuneering Presents Design and Methodology of Ongoing Phase 3 MAPKeeper 301 Trial at ESMO Congress 2026
Oct 26, 2026 07:30AM Davion Healthcare Announces US$25 Million Acquisition of Humaskan Medical Technology IP
Oct 26, 2026 07:30AM Quantum Cyber Invited to Present Quantum Antenna Technology at QuantumCT Quantum Sensing Convening
Oct 26, 2026 07:28AM Kailas FUGA Mogan Mountain Running Race Celebrates10 Years
Oct 26, 2026 07:24AM Danske Bank A/S, transactions by persons discharging managerial responsibilities
Oct 26, 2026 07:20AM 'Austin Marketers Connect' Approaches Capacity - Final Opportunity to Join an Exclusive Gathering of B2B Marketing & Growth Leaders
Oct 26, 2026 07:17AM Dot Ai Appoints Technology Industry Veteran Avi Cohen to Board of Directors
Oct 26, 2026 07:08AM Man Group PLC : Form 8.3 - Gamma Communications Plc
Oct 26, 2026 07:06AM MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer
Oct 26, 2026 07:05AM Kraig Biocraft Laboratories Launches Performance Yarn Development Program and Ships Spider Silk to Yarn and Aerospace Innovator
Oct 26, 2026 07:05AM Serapha Bio Announces Positive Interim Safety and Efficacy Data from the SERP-01 Investigator-Initiated Trial Presented at the ERS Alpha-1 Antitrypsin Conference 2026
Oct 26, 2026 07:05AM HBT Financial, Inc. Announces Third Quarter 2026 Financial Results
Oct 26, 2026 07:01AM Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 23 10 2026] - (CGWL)
Oct 26, 2026 07:00AM JPMorgan Announces Cash Distributions for the JPMorgan ETFs
Oct 26, 2026 07:00AM Electra Refinery Construction Remains on Budget as Workforce Doubles
Oct 26, 2026 07:00AM Lakeland Financial Reports Record Third Quarter Performance with Loan Growth of 8%; Diluted Earnings per Share Increases by 11%
Oct 26, 2026 07:00AM Abcourt Mines Produces 740 Ounces of Gold in September
Oct 26, 2026 07:00AM Origin Agritech's Three New Corn Varieties Pass Preliminary National Review, Advancing Toward Commercialization
Oct 26, 2026 07:01AM ARKO Corp. to Report Third Quarter 2026 Financial Results on November 5, 2026
Oct 26, 2026 07:01AM Heineken Holding N.V. reports transactions under its current share buyback programme
Oct 26, 2026 07:00AM Goldera Identifies Large Gold-Tungsten-Antimony Anomaly at Riley Brook, with Multiple Targets Remaining Open
Oct 26, 2026 07:00AM Nayax to Report 2026 Q3 Earnings on November 11, 2026
Oct 26, 2026 07:00AM AutoZone Chief Financial Officer Jamere Jackson to Depart November 25, 2026
Oct 26, 2026 07:00AM Xali Gold Submits FTA Application and Selects Drill Contractor for Pico Machay
Oct 26, 2026 07:00AM Harrow To Report Third Quarter 2026 Financial Results After Market Close on November 9, 2026
Oct 26, 2026 07:00AM Xtract One Technologies to Present at Planet MicroCap Toronto 2026 Powered by MicroCapClub
Oct 26, 2026 07:00AM Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026
Oct 26, 2026 07:00AM BPGbio Presents Phase 2 Glioblastoma Data Update at ESMO Congress 2026, Highlighting Median Overall Survival of 19.9 Months in MGMT-Unmethylated Patients
Oct 26, 2026 07:00AM HighPeak Energy, Inc. Announces 2026 Third Quarter Earnings Release and Conference Call Dates
Oct 26, 2026 07:00AM Gildan Completes Sale of HanesBrands Australia
Oct 26, 2026 07:00AM Can-Fite Presents Final Positive Data from Phase IIa Pancreatic Cancer Study of Namodenoson at ESMO 2026
Oct 26, 2026 07:00AM Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine
Oct 26, 2026 07:00AM Origin Agritech's Three New Corn Varieties Pass Preliminary National Review, Advancing Toward Commercialization
Oct 26, 2026 07:00AM Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026
Oct 26, 2026 07:00AM ARKO Petroleum Corp. to Report Third Quarter 2026 Financial Results on November 4, 2026
Oct 26, 2026 07:00AM Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasis
Oct 26, 2026 07:00AM Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology
View Older Stories